0000899243-23-002611.txt : 20230125 0000899243-23-002611.hdr.sgml : 20230125 20230125160021 ACCESSION NUMBER: 0000899243-23-002611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230123 FILED AS OF DATE: 20230125 DATE AS OF CHANGE: 20230125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kuriakose Emil CENTRAL INDEX KEY: 0001892413 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36644 FILM NUMBER: 23552479 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD, SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Calithera Biosciences, Inc. CENTRAL INDEX KEY: 0001496671 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272366329 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-870-1000 MAIL ADDRESS: STREET 1: 343 OYSTER POINT BLVD #200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-23 0 0001496671 Calithera Biosciences, Inc. CALA 0001892413 Kuriakose Emil C/O CALITHERA BIOSCIENCES, INC. 343 OYSTER POINT BLVD. #200 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 CHIEF MEDICAL OFFICER Common Stock 2023-01-23 4 F 0 79 0.4461 D 3539 D Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on January 23, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. Includes 125 shares acquired on each of June 10, 2022 and December 9, 2022, under the Company's 2014 Employee Stock Purchase Plan. /s/ Emil Kuriakose 2023-01-25